Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Knowledge of bladder cancer risk factors among patients diagnosed with nonmuscle-invasive bladder cancer
    Journal Article

    Matulewicz, R. S.; Whiting, K.; Bochner, B. H.; Ostroff, J. S.; Furberg, H.
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Focal therapy for prostate cancer: Evolutionary parallels to breast cancer treatment
    Review

    Labbate, C. V.; Klotz, L.; Morrow, M.; Cooperberg, M.; Esserman, L.; Eggener, S. E.
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Recommendations for the use of in silico approaches for next-generation sequencing bioinformatic pipeline validation: A joint report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists
    Guidelines

    Duncavage, E. J.; Coleman, J. F.; de Baca, M. E.; Kadri, S.; Leon, A.; Routbort, M.; Roy, S.; Suarez, C. J.; Vanderbilt, C.; Zook, J. M.
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82
    Correspondence

    Rubin, M. A.; Amin, M. B.; Compérat, E.; Gill, A.; Hartman, A.; Menon, S.; Raspollini, M.; Srigley, J.; Tan, P. H.; Ticktoo, S.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Key to our clinical care
    Editorial

    Rusch, V. W.
    Annals of Thoracic Surgery (2023)

    Fulltext@MSK | Save
  • Ttafasitamab plus lenalidomide (TAFA+LEN) versus pola-BR, r2, and CAR-T in non-transplant eligible (NTE) relapsed/refractory (r/r) DLBCL: A post hoc analysis of the RE-MIND2 study comparing multiple cohort-balancing approaches
    Meeting Abstract

    Córdoba, R.; Zinzani, P. L.; Joffe, E.; Yoon, D. H.; Peters, A.; Waltl, E. E.; Alvero, C.; Sabatelli, L.; Salles, G.; Nowakowski, G. S.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison (MAIC) of tepotinib with capmatinib in previously treated advanced non-small cell lung cancer (aNSCLC) with met exon 14 (METex14) skipping
    Meeting Abstract

    Paik, P.; Pfeiffer, B.; Vioix, H.; Postma, M. J.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Medical cannabis legalization and opioid- and pain- related outcomes among us patients newly diagnosed with cancer and receiving anti-cancer treatment
    Meeting Abstract

    Bao, Y.; Zhang, H.; Bruera, E.; Portenoy, R.; Rosa, W. E.; Reid, M. C.; Wen, H.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Physician perceptions on the treatment and health-related quality of life burden of Endogenous Cushing's syndrome
    Meeting Abstract

    Wilson, G. P.; Oak, B.; Silber, A.; Meyer, J.; O'Hara, M.; Geer, E. B.
    Value in Health (2022)

    Fulltext@MSK | Save